Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy.

ABSTRACT:

Introduction

Conventional treatment of pulmonary metastatic sarcoma primarily involves surgery, with systemic therapy added in select patients. However, broader applications of radiation therapy techniques have prompted investigation into the use of stereotactic body radiotherapy (SBRT) for treatment of metastatic sarcoma, an attractive non-invasive intervention with potential for lower rates of adverse events than surgery. Current data are limited to retrospective analyses. This study analyzed 2-year local control and overall survival and adverse events in patients prospectively treated with SBRT to pulmonary sarcoma metastases.

Methods

Patients prospectively treated with SBRT to the lung for biopsy-proven metastatic sarcoma at a single institution from 2010 to 2022 were in

SUBMITTER: Gutkin PM 

PROVIDER: S-EPMC9976442 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature